ArticleFrontiers in medicine2025
Development and validation of mortality risk prediction model for sepsis secondary to pneumonia at intensive care unit admission: a retrospective case-cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To establish a noninvasive mortality risk prediction model for sepsis secondary to pneumonia (SSP) and validate the model in the prediction of mortality risk in SSP patients at hospital admission. Methods: A retrospective cohort of SSP patients were recruited from January 2017 to December 2020 at the Henan Provincial People's Hospital. Clinical data were collected at admission. Least absolute shrinkage and selection operator and logistic regression were used to construct a prognosis prediction model. The predictive performance of the model was evaluated by receiver operating characteristic (ROC) curve. Another retrospective cohort with SSP was recruited from January 2021 to July 2022 at the same hospital to validate the model. Results: A total of 1,337 patients were screened, including 941 patients in the derivation cohort and 396 patients in the validation cohort. The model included age, white blood cell count, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, arterial oxygen pressure / fraction inspired oxygen, D-dimer and vasoactive drug use. The area under ROC curve of derivation model was better than sequential organ failure assessment score and APACHE II score (0.777 Conclusion: A prognosis model based on variables of SSP patients at hospital admission was developed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.